CD4 and prostate carcinoma: Our MR analysis showed that genetically‐predicted increased expression of ZNRD1 in CD4 + T cells was associated with increased risk of prostate cancer (OR = 1.06, p = 1.4 × 10−3), and the MR‐DEG test suggested the ZNRD1 effect as likely causal.